- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06511284
Ernæringsterapi hos pasienter med post-ekstubasjonsdysfagi
Svelge- og ernæringsterapi og dens innvirkning på kroppssammensetning og kliniske resultater hos pasienter med post-ekstubasjonsdysfagi
The aim of this study is to evaluate the impact of the prescription of two doses of protein on the amount in kilograms of muscle mass and on the clinical evolution (time until safe swallowing, time until removal of the feeding stoma, number of hospital readmissions, feeding stoma infections, incidence of pneumonia, functionality, number of falls, fractures and mortality) at 6 months after hospital discharge in patients with enteral nutrition due to post-extubation dysphagia.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Mexico City, Mexico, 14080
- National Institute of Respiratory Diseases
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients who required invasive mechanical ventilation during their hospital stay with a diagnosis of post-extubation dysphagia diagnosed by fibroendoscopy evaluation of swallowing (FEES).
- Patients who discharged with a feeding tube.
- Patients with signed informed consent.
Exclusion Criteria:
- Patients with pre-existing dysphagia, or with neurological conditions that can cause dysphagia (e.g. multiple sclerosis, Parkinson's disease, Alzheimer's, myasthenia gravis).
- Patients with chronic kidney disease, defined as a glomerular filtration rate <60 ml/min.
- Patients discharged with a terminal condition and/or life expectancy of less than 3 months.
- Diagnosis of HIV, upon receiving clinical follow-up by the team of specialists.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: High protein group
100% of the energy requirements measured by indirect calorimetry (IC) or estimated, and a protein intake of 2.0 g/kg, will be prescribed |
High dose of protein (2.0 g/kg) will prescribed for home enteral nutrition |
|
Annen: Usual protein group
100% of the energy requirements measured by IC or estimated, and a protein intake of 1.5 g/kg, will be prescribed. |
Usual dose of protein (1.5 g/kg) will prescribed for home enteral nutrition |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Muscle mass changes
Tidsramme: From randomization to 6 months
|
Changes of muscle mass in kilograms measured by impedance bioelectric |
From randomization to 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Swallow recovery
Tidsramme: From randomization to 6 months
|
Time to safe swallowing diagnosed by fibroendoscopy evaluation of swallowing (FEES) and measured in months |
From randomization to 6 months
|
|
Duration of enteral nutrition indication
Tidsramme: From randomization to 6 months
|
Time from discharge to feeding tube removal |
From randomization to 6 months
|
|
Feeding tube complications
Tidsramme: From randomization to 6 months
|
Number of feeding tube infections, dysfunctions and oclusions during study period |
From randomization to 6 months
|
|
Muscle functionality changes
Tidsramme: From randomization to 6 months
|
Changes in functionality measured by medical research council scale in a scale of 0-60 points |
From randomization to 6 months
|
|
Handgrip strenght changes
Tidsramme: From randomization to 6 months
|
Changes in functionality assessed by handgrip strenght in kilogramos using a digital dynamometer |
From randomization to 6 months
|
|
Frailty complications
Tidsramme: From randomization to 6 months
|
Number of falls and fractures during study period |
From randomization to 6 months
|
|
Hospital readmissions associated to dysphagia complications
Tidsramme: From randomization to 6 months
|
Number of hospital readmissions assocciated to feeding tube infections, dysfunctions and oclusions during study period |
From randomization to 6 months
|
|
6-month mortality
Tidsramme: From randomization to 6 months
|
All-cause mortality during study period |
From randomization to 6 months
|
|
Aspiration pneumonia incidence
Tidsramme: From randomization to 6 months
|
Number of hospital readmissions due to aspiration pneumonia |
From randomization to 6 months
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Ivan A Osuna-Padilla, PhD, Instituto Nacional de Enfermedades Respiratorias
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- C32-24
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .